BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25271083)

  • 21. Proline-rich region of non-muscle myosin light chain kinase modulates kinase activity and endothelial cytoskeletal dynamics.
    Belvitch P; Adyshev D; Elangovan VR; Brown ME; Naureckas C; Rizzo AN; Siegler JH; Garcia JG; Dudek SM
    Microvasc Res; 2014 Sep; 95():94-102. PubMed ID: 25072537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genes influenced by the non-muscle isoform of Myosin light chain kinase impact human cancer prognosis.
    Zhou T; Wang T; Garcia JG
    PLoS One; 2014; 9(4):e94325. PubMed ID: 24714365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative distribution and colocalization of non-muscle myosin light chain kinase isoforms and cortactin in human lung endothelium.
    Brown M; Adyshev D; Bindokas V; Moitra J; Garcia JG; Dudek SM
    Microvasc Res; 2010 Jul; 80(1):75-88. PubMed ID: 20053363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sp1-mediated nonmuscle myosin light chain kinase expression and enhanced activity in vascular endothelial growth factor-induced vascular permeability.
    Shimizu Y; Camp SM; Sun X; Zhou T; Wang T; Garcia JG
    Pulm Circ; 2015 Dec; 5(4):707-15. PubMed ID: 26697178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonmuscle Myosin Light Chain Kinase: A Key Player in Intermittent Hypoxia-Induced Vascular Alterations.
    Arnaud C; Bouyon S; Recoquillon S; Brasseur S; Lemarié E; Briançon-Marjollet A; Gonthier B; Toral M; Faury G; Martinez MC; Andriantsitohaina R; Pepin JL
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29371201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing of long noncoding RNA SRRM2-AS exerts suppressive effects on angiogenesis in nasopharyngeal carcinoma via activating MYLK-mediated cGMP-PKG signaling pathway.
    Chen S; Lv L; Zhan Z; Wang X; You Z; Luo X; You H
    J Cell Physiol; 2020 Nov; 235(11):7757-7768. PubMed ID: 31742692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction in endothelium of non-muscular myosin light-chain kinase and the NF-κB pathway is critical to lipopolysaccharide-induced vascular hyporeactivity.
    Recoquillon S; Carusio N; Lagrue-Lakhal AH; Tual-Chalot S; Filippelli A; Andriantsitohaina R; Martinez MC
    Clin Sci (Lond); 2015 Oct; 129(8):687-98. PubMed ID: 26201020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-muscular myosin light chain kinase triggers intermittent hypoxia-induced interleukin-6 release, endothelial dysfunction and permeability.
    Recoquillon S; Gómez-Guzmán M; Rodier M; Koffi C; Nitiéma M; Gagnadoux F; Martínez MC; Andriantsitohaina R
    Sci Rep; 2017 Oct; 7(1):13664. PubMed ID: 29057883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myosin, transgelin, and myosin light chain kinase: expression and function in asthma.
    Léguillette R; Laviolette M; Bergeron C; Zitouni N; Kogut P; Solway J; Kachmar L; Hamid Q; Lauzon AM
    Am J Respir Crit Care Med; 2009 Feb; 179(3):194-204. PubMed ID: 19011151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CircRNA_MYLK promotes malignant progression of ovarian cancer through regulating microRNA-652.
    Zhao Y; Hu Y; Shen Q; Chen Q; Zhu XJ; Jiang SS; Zhang Q
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5281-5291. PubMed ID: 32495861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single human myosin light chain kinase gene (MLCK; MYLK).
    Lazar V; Garcia JG
    Genomics; 1999 Apr; 57(2):256-67. PubMed ID: 10198165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single nucleotide polymorphisms in the MYLKP1 pseudogene are associated with increased colon cancer risk in African Americans.
    Lynn H; Sun X; Ayshiev D; Siegler JH; Rizzo AN; Karnes JH; Gonzales Garay M; Wang T; Casanova N; Camp SM; Ellis NA; Garcia JGN
    PLoS One; 2018; 13(8):e0200916. PubMed ID: 30161129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MYLK pathogenic variants aortic disease presentation, pregnancy risk, and characterization of pathogenic missense variants.
    Wallace SE; Regalado ES; Gong L; Janda AL; Guo DC; Russo CF; Kulmacz RJ; Hanna N; Jondeau G; Boileau C; Arnaud P; Lee K; Leal SM; Hannuksela M; Carlberg B; Johnston T; Antolik C; Hostetler EM; Colombo R; Milewicz DM
    Genet Med; 2019 Jan; 21(1):144-151. PubMed ID: 29925964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of non-muscle myosin light chain kinase in neutrophil-mediated intestinal barrier dysfunction during thermal injury.
    Guo M; Yuan SY; Frederich BJ; Sun C; Shen Q; McLean DL; Wu MH
    Shock; 2012 Oct; 38(4):436-43. PubMed ID: 22814287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of DNA sequence and mutant analyses and antisense oligodeoxynucleotides to examine the molecular basis of nonmuscle myosin light chain kinase autoinhibition, calmodulin recognition, and activity.
    Shoemaker MO; Lau W; Shattuck RL; Kwiatkowski AP; Matrisian PE; Guerra-Santos L; Wilson E; Lukas TJ; Van Eldik LJ; Watterson DM
    J Cell Biol; 1990 Sep; 111(3):1107-25. PubMed ID: 2202734
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Cho HW; Jin HS; Eom YB
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33800915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruptive mRNA folding increases translational efficiency of catechol-O-methyltransferase variant.
    Tsao D; Shabalina SA; Gauthier J; Dokholyan NV; Diatchenko L
    Nucleic Acids Res; 2011 Aug; 39(14):6201-12. PubMed ID: 21486747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution and expression of non-muscle myosin light chain kinase in rabbit livers.
    Zhu HQ; Wang Y; Hu RL; Ren B; Zhou Q; Jiang ZK; Gui SY
    World J Gastroenterol; 2003 Dec; 9(12):2715-9. PubMed ID: 14669320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonmuscle myosin light chain kinase activity modulates radiation-induced lung injury.
    Wang T; Mathew B; Wu X; Shimizu Y; Rizzo AN; Dudek SM; Weichselbaum RR; Jacobson JR; Hecker L; Garcia JG
    Pulm Circ; 2016 Jun; 6(2):234-9. PubMed ID: 27252850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-muscle Mlck is required for β-catenin- and FoxO1-dependent downregulation of Cldn5 in IL-1β-mediated barrier dysfunction in brain endothelial cells.
    Beard RS; Haines RJ; Wu KY; Reynolds JJ; Davis SM; Elliott JE; Malinin NL; Chatterjee V; Cha BJ; Wu MH; Yuan SY
    J Cell Sci; 2014 Apr; 127(Pt 8):1840-53. PubMed ID: 24522189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.